title: Employing Bayesian approach to the intermediate risk categories of the Bethesda thyroid cytopathology reporting system: can FDG PET/CT find a strong enough evidence-base to be practised clinically as an adjunct?
authors.affiliation: Radiation Medicine Centre (BARC), Tata Memorial Hospital Annexe, building, Jerbai Wadia Road, Parel, Mumbai, Maharashtra, India, drsanb@yahoo.com.
authors.forename: Sandip
authors.initials: S
authors.lastname: Basu
mesh_terms: D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D064847:Multimodal Imaging; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging*; D014057:Tomography, X-Ray Computed
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18